Who owns the IMMUNITAS THERAPEUTICS trademark?

The IMMUNITAS THERAPEUTICS trademark is owned by Immunitas Therapeutics, Inc..

What class is the IMMUNITAS THERAPEUTICS trademark registered in?

The IMMUNITAS THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for IMMUNITAS THERAPEUTICS?

The USPTO serial number for IMMUNITAS THERAPEUTICS is 88984877.

What is the registration number for IMMUNITAS THERAPEUTICS?

IMMUNITAS THERAPEUTICS is registered under USPTO registration number 6997137.

IMM

USPTO Trademark Record

REGISTERED

IMMUNITAS THERAPEUTICS

SN 88984877·Reg 6997137·Filed Dec 18, 2019

Owner Immunitas Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

IMMUNITAS THERAPEUTICS (Serial No. 88984877), Registration No. 6997137, is a registered US trademark filed on Dec 18, 2019 by Immunitas Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: March 07, 2029

Mark Intelligence

IMMUNITAS THERAPEUTICS (Reg. #6997137) is a registered US trademark that has been protecting its owner, Immunitas Therapeutics, Inc., since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 18, 2019

SERIAL

88984877

REG#

6997137

REGISTERED

Mar 07, 2023

Owner

Applicant

Immunitas Therapeutics, Inc.

Entity

Corporation

State

Address

830 Winter Street, Waltham, MA, 02451

Country

Attorney

NameJoshua Jarvis

Law firm

Joshua Jarvis FOLEY HOAG LLP

Docket

36592.00003

Address

155 SEAPORT BLVD., BOSTON, MA 02210-2600, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 18, 2019

Serial Number88984877

Registration No.6997137

Registration DateMar 07, 2023

Status DateMar 07, 2023

Published for OppositionApr 28, 2020

Mark TypeDesign with words

Attorney Docket36592.00003

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Sep 30, 2022

First use in commerce: Sep 30, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

REGISTERED-PRINCIPAL REGISTER

Mar 07, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 07, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 01, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 31, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 04, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 04, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

DIVISIONAL PROCESSING COMPLETE

Jan 03, 2023

DIVISIONAL PROCESSING COMPLETE

SOU EXTENSION 5 GRANTED

Jan 03, 2023

SOU EXTENSION 5 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 03, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Jan 03, 2023

STATEMENT OF USE PROCESSING COMPLETE

TEAS REQUEST TO DIVIDE RECEIVED

Dec 01, 2022

TEAS REQUEST TO DIVIDE RECEIVED

TEAS STATEMENT OF USE RECEIVED

Dec 01, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 01, 2022

USE AMENDMENT FILED

SOU TEAS EXTENSION RECEIVED

Dec 01, 2022

SOU TEAS EXTENSION RECEIVED

DIVISIONAL REQUEST RECEIVED

Dec 01, 2022

DIVISIONAL REQUEST RECEIVED

SOU EXTENSION 5 FILED

Dec 01, 2022

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 10, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 06, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

May 06, 2022

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

May 06, 2022

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 22, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 20, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Dec 20, 2021

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Dec 20, 2021

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 23, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Jun 21, 2021

SOU EXTENSION 2 GRANTED

SOU EXTENSION 2 FILED

Jun 21, 2021

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Jun 21, 2021

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 18, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Dec 16, 2020

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 16, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 16, 2020

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 23, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 28, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 28, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 08, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Mar 23, 2020

ASSIGNED TO LIE

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 17, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 17, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT E-MAILED

Mar 17, 2020

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 17, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINER'S AMENDMENT ENTERED

Mar 17, 2020

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Mar 17, 2020

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Dec 24, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Dec 21, 2019

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 21, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

IMMUNITAS THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Immunitas Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Joshua Jarvis

Resources

Company